relatlimab | dermcity

Oct 28, 20222 min read

Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery

Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...

Jan 7, 20222 min read

Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma

Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...

Featured Posts